Immunosuppression -- Risk factors. : The enemy within : the high cost of living near nuclear reactors : breast cancer, AIDS, low birthweights, and other radiation-induced immune deficiency effects / by Jay M. Gould, with members of the Radiation and Public Health Project, Ernest J. Sternglass, Joseph J. Mangano, William McDonnell
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs
The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc
Immunosuppressive Agents -- economics : Extending Medicare coverage for preventive and other services / Marilyn J. Field, Robert L. [i.e. Robert S.] Lawrence, and Lee Zwanziger, editors ; Committee on Medicare Coverage Extensions, Division of Health Care Services, Institute of Medicine
Immunosupressió. : Pharmacology of immunosuppression / Howard J. Eisen, editor
2022
1
Immunotaxonomy. : Toward precision medicine : building a knowledge network for biomedical research and a new taxonomy of disease / Committee on a framework for developing a new taxonomy of disease ; Board on Life Sciences ; Division on Earth and Life Studies
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection
Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Immunotherapy Breast Cancer : Principles of immunotherapy breast and gastrointestinal cancers : activity, mechanisms of resistance and new sensitization strategies / edited by Michele Ghidini
